文献速递垂体与肾上腺疾病

醛固酮合酶表达与横断面影像在侧化性原发性醛固酮增多症中的对比

Aldosterone synthase expression vs cross-sectional imaging in lateralized primary aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该单中心回顾性队列纳入2012至2024年间接受单侧肾上腺切除术的原发性醛固酮增多症(PA)患者,以盲法判读的横断面影像与肾上腺组织醛固酮合酶(CYP11B2)免疫组化(IHC)结果相互印证。结果显示,即便在侧化性PA中,IHC定位的醛固酮来源与影像所见一致者仅约一半,提示不宜依据横断面影像指导靶向治疗。

要点

  • 侧化性PA中,IHC与影像定位一致的病例仅占约一半。
  • IHC-影像不一致者常见影像显示额外结节或对侧结节。
  • 不宜仅凭横断面影像指导PA的靶向治疗。

核心结论

  • 即便在侧化性PA患者中,醛固酮来源的IHC定位与影像学所见一致者仅约半数,结果提示不宜以横断面影像指导靶向治疗。

研究设计与样本

  • 单转诊中心回顾性队列研究,纳入2012至2024年间接受单侧肾上腺切除术的PA患者,共173例,年龄52.6±11.8岁,119例(68.8%)为男性。

主要发现

  • CYP11B2 IHC显示单个醛固酮瘤(APA)87例(50.3%)、单个醛固酮结节(APN)38例(22.0%)、多发CYP11B2阳性灶45例(26.0%)、无CYP11B2阳性病灶3例。
  • IHC与影像均显示单一对应APA或APN者仅53/173(31%),另有38/173(22%)伴肾上腺增厚。
  • IHC与影像不一致者82例(47.4%),包括影像见额外结节、影像正常或单侧增生但IHC见明确阳性灶、以及影像与IHC对应但IHC另有阳性区域。
  • IHC-影像一致组女性比例和KCNJ5突变比例最高,不一致组以CACNA1D突变最常见。

临床怎么用

  • 对侧化性PA制定手术或靶向治疗策略时,应谨慎对待仅基于横断面影像的定位结论。

局限性

  • 为单中心回顾性队列研究,样本来自转诊中心,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adrenal vein sampling is the standard of care for guiding surgery in primary aldosteronism (PA). Because of its technical complexity and limited availability, however, many centers still use cross-sectional imaging for surgical guidance. DESIGN: Single referral-center retrospective cohort study of patients with PA who underwent unilateral adrenalectomy between 2012 and 2024. Blinded cross-sectional imaging interpretation was corroborated with aldosterone synthase (CYP11B2) immunohistochemistry (IHC) of formalin-fixed paraffin-embedded adrenal tissue. RESULTS: Of 173 patients, age 52.6 ± 11.8 years, 119 (68.8%) were men, 134 (77.5%) White, 30 (17.3%) Black, and 9 (5.2%) other races. CYP11B2 IHC identified a single aldosterone-producing adenoma (APA) or nodule (APN) in 87 (50.3%) and 38 (22.0%) patients, respectively; multiple CYP11B2-positive foci in 45 (26.0%) patients, and no CYP11B2-positive lesions in 3 patients. A single corresponding APA or APN on both IHC and imaging was found in only 53/173 (31%) patients, and an additional 38/173 (22%) patients also had adrenal thickening. Discrepant IHC-imaging findings were observed in 82 (47.4%) patients, including (1) additional nodule(s) on imaging (ipsilateral nonfunctional adenoma [n = 21], bilateral nodules [n = 29], or contralateral nodule(s) [n = 6]); (2) normal adrenals (n = 2) or unilateral adrenal hyperplasia (n = 4), but discrete CYP11B2-positive foci on IHC; and (3) corresponding APA/APN on imaging-IHC with additional CYP11B2-positive area(s) (n = 20). Patients with IHC-imaging concordance had the highest proportion of women and KCNJ5 mutations, while CACNA1D mutations were most frequent in the discordant group. CONCLUSION: Even in patients with lateralized PA, IHC mapping of aldosterone sources corresponded with imaging findings in approximately half of the cases. These data caution against targeted therapy guided by cross-sectional imaging.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mermejo LM, Liu Y, Caoili E, et al. Aldosterone synthase expression vs cross-sectional imaging in lateralized primary aldosteronism. J Clin Endocrinol Metab. 2026. PMID: 42089263. doi:10.1210/clinem/dgag194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。